Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACA | Q13085 | 4/20 | 0.65 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | DHODH | Q02127 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | ACP1 | P24666 | 1/20 | 0.51 |
| ▸ | BCL2 | P10415 | 1/20 | 0.51 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.50 |
| ▸ | TOP1 | P11387 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400688 | 1.00 | ACACA (0.65) | ACACAGRM2HPGDKDM4EMAPT | |
| SCHEMBL28251703 | 1.00 | ACACA (0.65) | ACACAGRM2HPGDKDM4EMAPT | |
| SCHEMBL4594838 | 0.91 | ACACA (0.75) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL4607752 | 0.89 | ACACA (0.73) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL29399315 | 0.89 | ACACA (0.72) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL1042853 | 0.89 | ACACA (0.72) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL18285493 | 0.88 | RXFP1 (0.58) | ACACAGRM2HPGDKDM4EMAPT | |
| SCHEMBL16990162 | 0.87 | ACACA (0.70) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL9610043 | 0.86 | RXFP1 (0.60) | ACACAHPGDKDM4EMAPTALDH1A1 | |
| SCHEMBL16203121 | 0.85 | ACACA (0.56) | ACACAGRM2HPGDKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111825722-B | Saturated red-light-emitting fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2023-06-09 | — | — | CN | claimed |
| CN-111825722-A | Saturated red luminescent fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2020-10-27 | — | — | CN | claimed |
| CN-111825722-B | Saturated red-light-emitting fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2023-06-09 | — | — | CN | disclosed |
| EP-3752512-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| CN-110724094-B | Quinoline compound and synthesis method thereof | 陕西科技大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-110156673-B | Method for preparing quinoline compound by catalysis of zirconocene dichloride | 陕西师范大学 | 2022-02-25 | — | — | CN | disclosed |
| CN-111825722-A | Saturated red luminescent fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2020-10-27 | — | — | CN | disclosed |
| CN-110724094-A | Quinoline compound and synthesis method thereof | 陕西科技大学 | 2020-01-24 | — | — | CN | disclosed |
| EP-2730634-B1 | NOVEL COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2019-10-09 | — | — | EP | disclosed |
| CN-110156673-A | The method that bis cyclopentadienyl zirconium dichloride catalysis prepares quinolines | 陕西师范大学 | 2019-08-23 | — | — | CN | disclosed |
| WO-2019158453-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-08-22 | — | — | WO | disclosed |
| US-20130043460-A1 | CARBAZOLE SERIAL COMPOUNDS | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-02-21 | — | — | US | disclosed |
| US-20130043460-A1 | CARBAZOLE SERIAL COMPOUNDS | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-02-21 | — | — | US | disclosed |
| US-20130043460-A1 | CARBAZOLE SERIAL COMPOUNDS | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-02-21 | — | — | US | disclosed |
| US-7867629-B2 | Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
| CN-101407492-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2009-04-15 | — | — | CN | disclosed |
| CN-101219987-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2008-07-16 | — | — | CN | disclosed |
| US-20060154105-A1 | Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-13 | — | — | US | disclosed |
| CN-1751024-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2006-03-22 | — | — | CN | disclosed |
| EP-1582516-A1 | NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130043460-A1 | CARBAZOLE SERIAL COMPOUNDS | CYCS, CBR3, AADAC | ACACA 1319/4885GRM2 4036/4885HPGD 3340/4885 |
| US-20060154105-A1 | Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same | L1CAM, NOTCH1, NUDC | ACACA 3382/4885GRM2 3670/4885HPGD 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.